Moreover, FoxO1 may negatively regulate SREBP1c-mediated fatty acid and cholesterol biosynthesis, which are up-regulated in cancer [184], by occupying and disrupting the assembly of the transcriptional initiation complex on the SREBP1c promoter [185]. Here, SREBF1 is linked to cancer.